DTIL: Precision Biosciences Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Precision Biosciences Inc (DTIL).
$29.23M Market Cap.
DTIL Market Cap. (MRY)
DTIL Shares Outstanding (MRY)
DTIL Assets (MRY)
Total Assets
$136.39M
Total Liabilities
$80.00M
Total Investments
$8.22M
DTIL Income (MRY)
Revenue
$68.70M
Net Income
$7.17M
Operating Expense
$94.86M
DTIL Cash Flow (MRY)
CF Operations
-$58.45M
CF Investing
-$215.00K
CF Financing
$50.45M
DTIL Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $136,388,000 (-14.64%) | $159,781,000 (-32.91%) | $238,169,000 (12.61%) | $211,498,000 (40.85%) |
Assets Current | $94,989,000 (-30.34%) | $136,359,000 (-31.51%) | $199,105,000 (23.09%) | $161,754,000 (53.23%) |
Assets Non-Current | $41,399,000 (76.75%) | $23,422,000 (-40.04%) | $39,064,000 (-21.47%) | $49,744,000 (11.55%) |
Goodwill & Intangible Assets | $622,000 (55.50%) | $400,000 (-45.28%) | $731,000 (-64.31%) | $2,048,000 (49.16%) |
Shareholders Equity | $56,393,000 (198.99%) | $18,861,000 (-68.79%) | $60,433,000 (-33.71%) | $91,168,000 (105.22%) |
Property Plant & Equipment Net | $10,179,000 (-30.29%) | $14,601,000 (5.97%) | $13,779,000 (-53.03%) | $29,334,000 (-29.32%) |
Cash & Equivalents | $108,468,000 (-7.04%) | $116,678,000 (-38.45%) | $189,576,000 (31.96%) | $143,663,000 (59.98%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $36,257,000 (-61.88%) | $95,117,000 (-31.60%) | $139,064,000 (41.53%) | $98,259,000 (16.75%) |
Total Investments | $8,221,000 (-59.09%) | $20,093,000 (67.69%) | $11,982,000 (-12.67%) | $13,721,000 (0%) |
Investments Current | $413,000 (-96.53%) | $11,897,000 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $7,808,000 (-4.73%) | $8,196,000 (-31.60%) | $11,982,000 (-12.67%) | $13,721,000 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $229,000 (-74.58%) | $901,000 (25.14%) | $720,000 (47.54%) | $488,000 (-95.12%) |
Trade & Non-Trade Payables | $1,312,000 (-55.80%) | $2,968,000 (354.52%) | $653,000 (-42.92%) | $1,144,000 (44.44%) |
Accumulated Retained Earnings (Deficit) | -$482,464,000 (1.46%) | -$489,631,000 (-14.32%) | -$428,312,000 (-35.25%) | -$316,675,000 (-10.70%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $30,045,000 (-3.91%) | $31,268,000 (25.27%) | $24,960,000 (173.89%) | $9,113,000 (-13.37%) |
Debt Current | $1,320,000 (-94.39%) | $23,545,000 (1303.16%) | $1,678,000 (-7.90%) | $1,822,000 (-5.74%) |
Debt Non-Current | $28,725,000 (271.94%) | $7,723,000 (-66.83%) | $23,282,000 (219.33%) | $7,291,000 (-15.08%) |
Total Liabilities | $79,995,000 (-43.23%) | $140,920,000 (-20.71%) | $177,736,000 (47.71%) | $120,330,000 (13.81%) |
Liabilities Current | $14,980,000 (-70.03%) | $49,987,000 (-16.22%) | $59,664,000 (65.83%) | $35,980,000 (-15.99%) |
Liabilities Non-Current | $65,015,000 (-28.50%) | $90,933,000 (-22.99%) | $118,072,000 (39.98%) | $84,350,000 (34.09%) |
DTIL Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $68,696,000 (40.98%) | $48,727,000 (94.15%) | $25,098,000 (-78.28%) | $115,529,000 (375.72%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $35,299,000 (-9.69%) | $39,088,000 (-5.32%) | $41,284,000 (4.08%) | $39,667,000 (10.03%) |
Research & Development Expense | $59,559,000 (11.59%) | $53,375,000 (15.73%) | $46,122,000 (-59.98%) | $115,238,000 (17.52%) |
Operating Expenses | $94,858,000 (2.59%) | $92,463,000 (5.79%) | $87,406,000 (-43.57%) | $154,905,000 (15.50%) |
Interest Expense | $1,782,000 (-20.09%) | $2,230,000 (100.72%) | $1,111,000 (741.67%) | $132,000 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $18,792,000 (-51.48%) | $38,728,000 (0%) | $0 (0%) |
Consolidated Income | $7,167,000 (111.69%) | -$61,319,000 (45.07%) | -$111,637,000 (-264.80%) | -$30,602,000 (71.93%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | $7,167,000 (111.69%) | -$61,319,000 (45.07%) | -$111,637,000 (-264.80%) | -$30,602,000 (71.93%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | $7,167,000 (111.69%) | -$61,319,000 (45.07%) | -$111,637,000 (-264.80%) | -$30,602,000 (71.93%) |
Weighted Average Shares | $6,832,982 (77.88%) | $3,841,405 (31.11%) | $2,929,873 (49.77%) | $1,956,270 (12.79%) |
Weighted Average Shares Diluted | $6,883,911 (79.20%) | $3,841,405 (31.11%) | $2,929,873 (49.77%) | $1,956,270 (12.79%) |
Earning Before Interest & Taxes (EBIT) | $8,949,000 (115.14%) | -$59,089,000 (46.54%) | -$110,526,000 (-262.74%) | -$30,470,000 (72.05%) |
Gross Profit | $68,696,000 (40.98%) | $48,727,000 (94.15%) | $25,098,000 (-78.28%) | $115,529,000 (375.72%) |
Operating Income | -$26,162,000 (40.18%) | -$43,736,000 (29.81%) | -$62,308,000 (-58.24%) | -$39,376,000 (64.15%) |
DTIL Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$215,000 (-103.69%) | $5,829,000 (275.63%) | -$3,319,000 (42.81%) | -$5,803,000 (-15.34%) |
Net Cash Flow from Financing | $50,450,000 (836.51%) | $5,387,000 (-94.33%) | $94,985,000 (34.69%) | $70,521,000 (5206.32%) |
Net Cash Flow from Operations | -$58,445,000 (30.52%) | -$84,114,000 (-83.84%) | -$45,753,000 (-321.57%) | -$10,853,000 (87.58%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$8,210,000 (88.74%) | -$72,898,000 (-258.77%) | $45,913,000 (-14.76%) | $53,865,000 (159.14%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $8,000,000 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$190,000 (89.73%) | -$1,850,000 (44.26%) | -$3,319,000 (34.32%) | -$5,053,000 (-0.44%) |
Issuance (Repayment) of Debt Securities | -$37,000 (0%) | $0 (0%) | $19,805,000 (706.06%) | $2,457,000 (0%) |
Issuance (Purchase) of Equity Shares | $50,487,000 (837.20%) | $5,387,000 (-92.83%) | $75,180,000 (22.68%) | $61,281,000 (4511.06%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $12,604,000 (-10.23%) | $14,040,000 (-26.86%) | $19,197,000 (16.25%) | $16,514,000 (19.79%) |
Depreciation Amortization & Accretion | $4,577,000 (-44.55%) | $8,255,000 (-8.32%) | $9,004,000 (-11.70%) | $10,197,000 (3.91%) |
DTIL Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) |
Profit Margin | 10.40% (108.27%) | -125.80% (71.72%) | -444.80% (-1578.49%) | -26.50% (94.10%) |
EBITDA Margin | 19.70% (118.89%) | -104.30% (74.22%) | -404.50% (-2211.43%) | -17.50% (95.72%) |
Return on Average Equity (ROAE) | 12.30% (106.13%) | -200.80% (-42.82%) | -140.60% (-304.02%) | -34.80% (75.35%) |
Return on Average Assets (ROAA) | 4.50% (113.04%) | -34.50% (23.67%) | -45.20% (-245.04%) | -13.10% (78.45%) |
Return on Sales (ROS) | 13.00% (110.72%) | -121.30% (72.46%) | -440.40% (-1568.18%) | -26.40% (94.12%) |
Return on Invested Capital (ROIC) | 27.30% (103.72%) | -733.90% (-173.64%) | -268.20% (-159.88%) | -103.20% (67.49%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | 3.63 (629.01%) | -0.69 (26.79%) | -0.94 (93.42%) | -14.23 (-256.67%) |
Price to Sales Ratio (P/S) | 0.38 (-56.08%) | 0.86 (-79.29%) | 4.17 (10.88%) | 3.76 (-78.96%) |
Price to Book Ratio (P/B) | 0.52 (-77.50%) | 2.3 (5.35%) | 2.19 (-55.70%) | 4.93 (-49.94%) |
Debt to Equity Ratio (D/E) | 1.42 (-81.01%) | 7.47 (154.06%) | 2.94 (122.80%) | 1.32 (-44.54%) |
Earnings Per Share (EPS) | 1.05 (106.58%) | -15.96 (58.11%) | -38.1 (-144.23%) | -15.6 (75.12%) |
Sales Per Share (SPS) | 10.05 (-20.74%) | 12.69 (48.09%) | 8.57 (-85.50%) | 59.06 (321.77%) |
Free Cash Flow Per Share (FCFPS) | -8.58 (61.65%) | -22.38 (-33.61%) | -16.75 (-105.99%) | -8.13 (84.74%) |
Book Value Per Share (BVPS) | 8.25 (68.09%) | 4.91 (-76.20%) | 20.63 (-55.74%) | 46.6 (81.94%) |
Tangible Assets Book Value Per Share (TABVPS) | 19.87 (-52.11%) | 41.49 (-48.80%) | 81.04 (-24.31%) | 107.07 (24.81%) |
Enterprise Value Over EBIT (EV/EBIT) | -7 (-800.00%) | 1 (0%) | 0 (0%) | -10 (-233.33%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -4.57 (-400.39%) | 1.52 (193.63%) | 0.52 (103.52%) | -14.71 (-323.67%) |
Asset Turnover | 0.43 (56.57%) | 0.27 (168.63%) | 0.1 (-79.44%) | 0.5 (267.41%) |
Current Ratio | 6.34 (132.44%) | 2.73 (-18.25%) | 3.34 (-25.78%) | 4.5 (82.39%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$58,635,000 (31.79%) | -$85,964,000 (-75.18%) | -$49,072,000 (-208.51%) | -$15,906,000 (82.79%) |
Enterprise Value (EV) | -$61,794,265 (20.09%) | -$77,325,655 (-47.14%) | -$52,550,844 (-117.62%) | $298,296,072 (-13.41%) |
Earnings Before Tax (EBT) | $7,167,000 (111.69%) | -$61,319,000 (45.07%) | -$111,637,000 (-264.80%) | -$30,602,000 (71.93%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $13,526,000 (126.61%) | -$50,834,000 (49.93%) | -$101,522,000 (-400.77%) | -$20,273,000 (79.56%) |
Invested Capital | $42,363,000 (76.63%) | $23,984,000 (82.28%) | $13,158,000 (-66.19%) | $38,920,000 (45.89%) |
Working Capital | $80,009,000 (-7.37%) | $86,372,000 (-38.06%) | $139,441,000 (10.87%) | $125,774,000 (100.48%) |
Tangible Asset Value | $135,766,000 (-14.82%) | $159,381,000 (-32.87%) | $237,438,000 (13.36%) | $209,450,000 (40.77%) |
Market Capitalization | $29,226,735 (-32.67%) | $43,411,345 (-67.12%) | $132,041,156 (-70.64%) | $449,678,072 (2.74%) |
Average Equity | $58,294,750 (90.91%) | $30,535,500 (-61.53%) | $79,373,750 (-9.80%) | $87,996,500 (13.95%) |
Average Assets | $160,046,750 (-9.87%) | $177,581,000 (-28.14%) | $247,104,000 (6.15%) | $232,781,750 (29.82%) |
Invested Capital Average | $32,821,250 (307.67%) | $8,051,000 (-80.46%) | $41,211,500 (39.57%) | $29,526,500 (-14.02%) |
Shares | 7,671,059 (93.49%) | 3,964,506 (7.19%) | 3,698,632 (82.60%) | 2,025,577 (15.79%) |
